Functional Respiratory Imaging After Neostigmine or Sugammadex

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

April 30, 2015

Conditions
Respiratory-Gated Imaging Techniques
Interventions
DRUG

Neostigmine

At a train-of-four (TOF) ratio of 0.5: administration of neostigmine 0.06 mg/kg for reversal of neuromuscular blockade.

DRUG

Sugammadex

At a train-of-four (TOF) ratio of 0.5: administration of sugammadex 15 mg/kg for reversal of neuromuscular blockade.

DRUG

Water for injection

At a train-of-four (TOF) ratio of 0.5: administration of placebo for spontaneous recovery of neuromuscular blockade.

Trial Locations (1)

9300

OLV Hospital, Aalst

All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

collaborator

MSD Belgium BVBA

INDUSTRY

lead

Onze Lieve Vrouw Hospital

OTHER

NCT02284412 - Functional Respiratory Imaging After Neostigmine or Sugammadex | Biotech Hunter | Biotech Hunter